Patient‐defined Duration of Benefit from Juvederm (hyaluronic Acid) Used in Injection Laryngoplasty
The Laryngoscope(2019)
摘要
Injection laryngoplasty has become valuable in treating laryngologic disorders including vocal cord atrophy, paralysis, and paresis. Although materials such as carboxymethylcellulose and calcium hydroxylapatite are Food and Drug Administration (FDA) approved, they are not without limitations. Juvederm (hyaluronic acid) is an alternative treatment that is not FDA approved. Although studies have examined Juvederm's longevity in cutaneous injections, there are limited data examining durability of Juvederm used in laryngoplasty. We aimed to determine the longevity and effectiveness of Juvederm used in injection laryngoplasty.
更多查看译文
关键词
Injection laryngoplasty,Juvederm,hyaluronic acid,dysphonia,vocal cord paralysis,vocal cord paresis,vocal cord atrophy,glottic insufficiency
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要